These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28244737)

  • 21. Cell-Based Assay Design for High-Content Screening of Drug Candidates.
    Nierode G; Kwon PS; Dordick JS; Kwon SJ
    J Microbiol Biotechnol; 2016 Feb; 26(2):213-25. PubMed ID: 26428732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DiSCuS: an open platform for (not only) virtual screening results management.
    Wójcikowski M; Zielenkiewicz P; Siedlecki P
    J Chem Inf Model; 2014 Jan; 54(1):347-54. PubMed ID: 24364790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GPCR assay automation for leveraging lead optimization.
    Cvijic ME; Chen J; Kubala S; Nolfo J; Kolodin G; Zhang L
    J Lab Autom; 2012 Aug; 17(4):266-74. PubMed ID: 22505604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on ion channel transporters as a target for the drug discovery].
    Imaizumi Y; Kaneko S
    Nihon Yakurigaku Zasshi; 2011 Dec; 138(6):227. PubMed ID: 22303567
    [No Abstract]   [Full Text] [Related]  

  • 25. How to Triage PAINS-Full Research.
    Dahlin JL; Walters MA
    Assay Drug Dev Technol; 2016 Apr; 14(3):168-74. PubMed ID: 26496388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organs-on-chips at the frontiers of drug discovery.
    Esch EW; Bahinski A; Huh D
    Nat Rev Drug Discov; 2015 Apr; 14(4):248-60. PubMed ID: 25792263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in virtual screening for drug discovery.
    Leung CH; Ma DL
    Methods; 2015 Jan; 71():1-3. PubMed ID: 25542642
    [No Abstract]   [Full Text] [Related]  

  • 28. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Screening Assay Cascade to Identify and Characterize Novel Selective Estrogen Receptor Downregulators (SERDs).
    Callis R; Rabow A; Tonge M; Bradbury R; Challinor M; Roberts K; Jones K; Walker G
    J Biomol Screen; 2015 Jul; 20(6):748-59. PubMed ID: 25851036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Building a discovery partnership with Sarawak Biodiversity Centre: a gateway to access natural products from the rainforests.
    Yeo TC; Naming M; Manurung R
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):192-200. PubMed ID: 24409959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypothesis-driven screening.
    Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
    Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.
    Baell JB; Holloway GA
    J Med Chem; 2010 Apr; 53(7):2719-40. PubMed ID: 20131845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An efficient method for the detection and elimination of systematic error in high-throughput screening.
    Makarenkov V; Zentilli P; Kevorkov D; Gagarin A; Malo N; Nadon R
    Bioinformatics; 2007 Jul; 23(13):1648-57. PubMed ID: 17463024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-Based Virtual Screening.
    Li Q; Shah S
    Methods Mol Biol; 2017; 1558():111-124. PubMed ID: 28150235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving lead generation success through integrated methods: transcending 'drug discovery by numbers'.
    Campbell JB
    IDrugs; 2010 Dec; 13(12):874-9. PubMed ID: 21154146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of data integrity on decision making in early lead discovery.
    Beck B; Seeliger D; Kriegl JM
    J Comput Aided Mol Des; 2015 Sep; 29(9):911-21. PubMed ID: 26409840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic screening meets natural products in drug discovery.
    Futamura Y; Yamamoto K; Osada H
    Biosci Biotechnol Biochem; 2017 Jan; 81(1):28-31. PubMed ID: 27885937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-silico approaches to multi-target drug discovery : computer aided multi-target drug design, multi-target virtual screening.
    Ma XH; Shi Z; Tan C; Jiang Y; Go ML; Low BC; Chen YZ
    Pharm Res; 2010 May; 27(5):739-49. PubMed ID: 20221898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformed insect cells as high throughput screening tools for the discovery of new bioactive compounds.
    Swevers L; Farrell PJ; Kravariti L; Xenou-Kokoletsi M; Sdralia N; Lioupis A; Morou E; Balatsos NA; Douris V; Georgoussi Z; Mazomenos B; Iatrou K
    Commun Agric Appl Biol Sci; 2003; 68(2 Pt B):333-41. PubMed ID: 24757768
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.